Johnson & Johnson Q4 Earnings Beat Expectations but 2025 Sales Forecast Disappoints
Aaron McDade
Aaron McDade 1 year ago
Senior Breaking News Reporter #Company News
0
5.3K

Johnson & Johnson Q4 Earnings Beat Expectations but 2025 Sales Forecast Disappoints

Discover how Johnson & Johnson surpassed adjusted earnings estimates in Q4 yet revealed a conservative sales outlook for 2025, impacting investor sentiment.

Highlights

  • Johnson & Johnson’s Q4 revenue aligned with forecasts, though net income lagged behind.
  • Adjusted profits, excluding one-time expenses like acquisitions, exceeded analyst predictions.
  • 2025 sales guidance fell short of market expectations, signaling cautious growth.

Johnson & Johnson (JNJ) released its Q4 financial results, showcasing adjusted earnings that surpassed market estimates while projecting a more modest sales growth for fiscal year 2025.

The healthcare giant reported $22.52 billion in revenue, matching analyst forecasts from Visible Alpha. However, net income was reported at $3.43 billion ($1.41 per share), below the anticipated $4.41 billion ($1.79 per share).

When factoring out one-time charges such as asset amortization and acquisition-related costs, adjusted net income reached $4.94 billion, slightly surpassing the consensus estimate of $4.88 billion.

Looking ahead to 2025, Johnson & Johnson projects revenue between $89.2 billion and $90 billion, with adjusted earnings per share ranging from $10.50 to $10.70. These figures fall short of Visible Alpha’s analyst consensus, which forecasts $91.18 billion in revenue and $10.54 in adjusted EPS.

Pharmaceutical and medical technology divisions each demonstrated growth, with sales increasing by 4.4% and 6.7% year-over-year, respectively.

Following the earnings release, Johnson & Johnson shares dipped over 1% in early trading.

Discover engaging topics and analytical content in Company News as of 08-08-2024. The article titled " Johnson & Johnson Q4 Earnings Beat Expectations but 2025 Sales Forecast Disappoints " provides new insights and practical guidance in the Company News field. Each topic is meticulously analyzed to deliver actionable information to readers.

The topic " Johnson & Johnson Q4 Earnings Beat Expectations but 2025 Sales Forecast Disappoints " helps you make smarter decisions within the Company News category. All topics on our website are unique and offer valuable content for our audience.

0
5.3K

InLiber is a global news platform delivering fast, accurate, and trustworthy information from around the world.

We cover breaking news and insights across technology, politics, health, sports, culture, finance, and more. Designed for all internet users, InLiber provides a user-friendly interface, verified sources, and in-depth coverage to keep you informed in the digital age.